{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T15:34:52Z","timestamp":1795102492862,"version":"4.10.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20230484348"],"award-info":[{"award-number":["20230484348"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81170236"],"award-info":[{"award-number":["81170236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31127001"],"award-info":[{"award-number":["31127001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04507-y","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T16:00:35Z","timestamp":1754409635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A scalable platform for EPSC-Induced MSC extracellular vesicles with therapeutic potential"],"prefix":"10.1186","volume":"16","author":[{"given":"Shixin","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinqing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zemin","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjiang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7059-0788","authenticated-orcid":false,"given":"Lida","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"4507_CR1","doi-asserted-by":"publisher","unstructured":"Keshtkar S, Azarpira N, Ghahremani MH. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther. 2018;9. https:\/\/doi.org\/10.1186\/s13287-018-0791-7.","DOI":"10.1186\/s13287-018-0791-7"},{"key":"4507_CR2","doi-asserted-by":"publisher","unstructured":"Weng Z, et al. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer. J Hematol Oncol. 2021;14. https:\/\/doi.org\/10.1186\/s13045-021-01141-y.","DOI":"10.1186\/s13045-021-01141-y"},{"key":"4507_CR3","doi-asserted-by":"publisher","unstructured":"Tan F, et al. Clinical applications of stem cell-derived exosomes. Signal Transduct Target Ther. 2024;9. https:\/\/doi.org\/10.1038\/s41392-023-01704-0.","DOI":"10.1038\/s41392-023-01704-0"},{"key":"4507_CR4","doi-asserted-by":"publisher","first-page":"100910","DOI":"10.1016\/j.mtbio.2023.100910","volume":"24","author":"X Wu","year":"2024","unstructured":"Wu X, et al. The mechanism of adipose mesenchymal stem cells to stabilize the immune microenvironment of pelvic floor injury by regulating pyroptosis and promoting tissue repair. Mater Today Bio. 2024;24:100910. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100910.","journal-title":"Mater Today Bio"},{"key":"4507_CR5","doi-asserted-by":"publisher","unstructured":"Kolios G, Paspaliaris V. Mesenchyme stem Cell-Derived conditioned medium as a potential therapeutic tool in idiopathic pulmonary fibrosis. Biomedicines. 2022;10. https:\/\/doi.org\/10.3390\/biomedicines10092298.","DOI":"10.3390\/biomedicines10092298"},{"key":"4507_CR6","doi-asserted-by":"publisher","first-page":"e12361","DOI":"10.1002\/jev2.12361","volume":"12","author":"R Huang","year":"2023","unstructured":"Huang R, et al. Plant exosomes fused with engineered mesenchymal stem cell-derived nanovesicles for synergistic therapy of autoimmune skin disorders. J Extracell Vesicles. 2023;12:e12361. https:\/\/doi.org\/10.1002\/jev2.12361.","journal-title":"J Extracell Vesicles"},{"key":"4507_CR7","doi-asserted-by":"publisher","unstructured":"Kundu D, Shin SY, Chilian WM, Dong F. The potential of mesenchymal stem Cell-Derived exosomes in cardiac repair. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms252413494.","DOI":"10.3390\/ijms252413494"},{"key":"4507_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13287-024-03863-5","volume":"15","author":"B Zhou","year":"2024","unstructured":"Zhou B, et al. Therapeutic potential of adipose-derived stem cell extracellular vesicles: from inflammation regulation to tissue repair. Stem Cell Res Ther. 2024;15:249. https:\/\/doi.org\/10.1186\/s13287-024-03863-5.","journal-title":"Stem Cell Res Ther"},{"key":"4507_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.7150\/thno.16154","volume":"7","author":"M Monguio-Tortajada","year":"2017","unstructured":"Monguio-Tortajada M, et al. Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine. Theranostics. 2017;7:270\u201384. https:\/\/doi.org\/10.7150\/thno.16154.","journal-title":"Theranostics"},{"key":"4507_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s13287-021-02542-z","volume":"12","author":"M Abdelgawad","year":"2021","unstructured":"Abdelgawad M, Bakry NS, Farghali AA, Abdel-Latif A, Lotfy A. Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects. Stem Cell Res Ther. 2021;12:469. https:\/\/doi.org\/10.1186\/s13287-021-02542-z.","journal-title":"Stem Cell Res Ther"},{"key":"4507_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13287-023-03287-7","volume":"14","author":"A Lotfy","year":"2023","unstructured":"Lotfy A, AboQuella NM, Wang H. Mesenchymal stromal\/stem cell (MSC)-derived exosomes in clinical trials. Stem Cell Res Ther. 2023;14:66. https:\/\/doi.org\/10.1186\/s13287-023-03287-7.","journal-title":"Stem Cell Res Ther"},{"key":"4507_CR12","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.7150\/thno.72289","volume":"12","author":"M Monguio-Tortajada","year":"2022","unstructured":"Monguio-Tortajada M, et al. Acellular cardiac scaffolds enriched with MSC-derived extracellular vesicles limit ventricular remodelling and exert local and systemic Immunomodulation in a myocardial infarction Porcine model. Theranostics. 2022;12:4656\u201370. https:\/\/doi.org\/10.7150\/thno.72289.","journal-title":"Theranostics"},{"key":"4507_CR13","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1016\/j.bioactmat.2021.02.026","volume":"6","author":"M Monguio-Tortajada","year":"2021","unstructured":"Monguio-Tortajada M, et al. Local administration of Porcine immunomodulatory, chemotactic and angiogenic extracellular vesicles using engineered cardiac scaffolds for myocardial infarction. Bioact Mater. 2021;6:3314\u201327. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.02.026.","journal-title":"Bioact Mater"},{"key":"4507_CR14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12951-022-01668-3","volume":"20","author":"R Zhang","year":"2022","unstructured":"Zhang R, et al. An optimized exosome production strategy for enhanced yield while without sacrificing cargo loading efficiency. J Nanobiotechnol. 2022;20:463. https:\/\/doi.org\/10.1186\/s12951-022-01668-3.","journal-title":"J Nanobiotechnol"},{"key":"4507_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13287-018-0876-3","volume":"9","author":"YK Yang","year":"2018","unstructured":"Yang YK, Ogando CR, Wang See C, Chang TY, Barabino GA. Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro. Stem Cell Res Ther. 2018;9:131. https:\/\/doi.org\/10.1186\/s13287-018-0876-3.","journal-title":"Stem Cell Res Ther"},{"key":"4507_CR16","doi-asserted-by":"publisher","first-page":"1434465","DOI":"10.3389\/fbioe.2024.1434465","volume":"12","author":"X Zhou","year":"2024","unstructured":"Zhou X, et al. The application potential of iMSCs and iMSC-EVs in diseases. Front Bioeng Biotechnol. 2024;12:1434465. https:\/\/doi.org\/10.3389\/fbioe.2024.1434465.","journal-title":"Front Bioeng Biotechnol"},{"key":"4507_CR17","doi-asserted-by":"publisher","first-page":"108092","DOI":"10.1016\/j.biotechadv.2022.108092","volume":"63","author":"S Giancaterino","year":"2023","unstructured":"Giancaterino S, Boi C. Alternative biological sources for extracellular vesicles production and purification strategies for process scale-up. Biotechnol Adv. 2023;63:108092. https:\/\/doi.org\/10.1016\/j.biotechadv.2022.108092.","journal-title":"Biotechnol Adv"},{"key":"4507_CR18","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1002\/bit.28378","volume":"120","author":"MHG Costa","year":"2023","unstructured":"Costa MHG, et al. Enhanced bioprocess control to advance the manufacture of mesenchymal stromal cell-derived extracellular vesicles in stirred-tank bioreactors. Biotechnol Bioeng. 2023;120:2725\u201341. https:\/\/doi.org\/10.1002\/bit.28378.","journal-title":"Biotechnol Bioeng"},{"key":"4507_CR19","doi-asserted-by":"publisher","first-page":"e2300635","DOI":"10.1002\/biot.202300635","volume":"19","author":"VN Goral","year":"2024","unstructured":"Goral VN, et al. Innovative fixed bed bioreactor platform: enabling linearly scalable adherent cell biomanufacturing with real-time biomass prediction from nutrient consumption. Biotechnol J. 2024;19:e2300635. https:\/\/doi.org\/10.1002\/biot.202300635.","journal-title":"Biotechnol J"},{"key":"4507_CR20","doi-asserted-by":"publisher","unstructured":"Li R et al. Generation of Blastocyst-like Structures from Mouse Embryonic and Adult Cell Cultures. Cell 179, 687\u2013702 e618. https:\/\/doi.org\/10.1016\/j.cell.2019.09.029 (2019).","DOI":"10.1016\/j.cell.2019.09.029"},{"key":"4507_CR21","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1038\/s41467-021-23320-8","volume":"12","author":"B Liu","year":"2021","unstructured":"Liu B, et al. Chemically defined and xeno-free culture condition for human extended pluripotent stem cells. Nat Commun. 2021;12:3017. https:\/\/doi.org\/10.1038\/s41467-021-23320-8.","journal-title":"Nat Commun"},{"key":"4507_CR22","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nbt761","volume":"20","author":"RH Xu","year":"2002","unstructured":"Xu RH, et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol. 2002;20:1261\u20134. https:\/\/doi.org\/10.1038\/nbt761.","journal-title":"Nat Biotechnol"},{"key":"4507_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/stem.2242","volume":"34","author":"X Wang","year":"2016","unstructured":"Wang X, et al. Immune modulatory mesenchymal stem cells derived from human embryonic stem cells through a trophoblast-like stage. Stem Cells. 2016;34:380\u201391. https:\/\/doi.org\/10.1002\/stem.2242.","journal-title":"Stem Cells"},{"key":"4507_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.placenta.2007.10.009","volume":"29","author":"LC Schulz","year":"2008","unstructured":"Schulz LC, et al. Human embryonic stem cells as models for trophoblast differentiation. Placenta. 2008;29:10\u20136. https:\/\/doi.org\/10.1016\/j.placenta.2007.10.009. Suppl A.","journal-title":"Placenta"},{"key":"4507_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13287-025-04185-w","volume":"16","author":"M Koczkowska","year":"2025","unstructured":"Koczkowska M, et al. Identifying differentiation markers between dermal fibroblasts and adipose-derived mesenchymal stromal cells (AD-MSCs) in human visceral and subcutaneous tissues using single-cell transcriptomics. Stem Cell Res Ther. 2025;16:64. https:\/\/doi.org\/10.1186\/s13287-025-04185-w.","journal-title":"Stem Cell Res Ther"},{"key":"4507_CR26","doi-asserted-by":"publisher","first-page":"e0137255","DOI":"10.1371\/journal.pone.0137255","volume":"10","author":"RK Okolicsanyi","year":"2015","unstructured":"Okolicsanyi RK, et al. Human mesenchymal stem cells retain multilineage differentiation capacity including neural marker expression after extended in vitro expansion. PLoS ONE. 2015;10:e0137255. https:\/\/doi.org\/10.1371\/journal.pone.0137255.","journal-title":"PLoS ONE"},{"key":"4507_CR27","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s13287-022-03038-0","volume":"13","author":"Y Rao","year":"2022","unstructured":"Rao Y, et al. Tenogenic induction of human adipose-derived stem cells by soluble tendon extracellular matrix: composition and transcriptomic analyses. Stem Cell Res Ther. 2022;13:380. https:\/\/doi.org\/10.1186\/s13287-022-03038-0.","journal-title":"Stem Cell Res Ther"},{"key":"4507_CR28","doi-asserted-by":"publisher","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367. https:\/\/doi.org\/10.1126\/science.aau6977.","DOI":"10.1126\/science.aau6977"},{"key":"4507_CR29","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13:e12404. https:\/\/doi.org\/10.1002\/jev2.12404.","journal-title":"J Extracell Vesicles"},{"key":"4507_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1183\/09031936.03.00037902","volume":"21","author":"I Tsangaris","year":"2003","unstructured":"Tsangaris I, Lekka ME, Kitsiouli E, Constantopoulos S, Nakos G. Bronchoalveolar lavage alterations during prolonged ventilation of patients without acute lung injury. Eur Respir J. 2003;21:495\u2013501. https:\/\/doi.org\/10.1183\/09031936.03.00037902.","journal-title":"Eur Respir J"},{"key":"4507_CR31","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376. https:\/\/doi.org\/10.1016\/j.cell.2006.07.024.","journal-title":"Cell"},{"key":"4507_CR32","doi-asserted-by":"publisher","unstructured":"Xu H et al. Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility. Cell Stem Cell 24, 566\u2013578 e567. https:\/\/doi.org\/10.1016\/j.stem.2019.02.005 (2019).","DOI":"10.1016\/j.stem.2019.02.005"},{"key":"4507_CR33","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1182\/blood.2022016205","volume":"141","author":"F Cichocki","year":"2023","unstructured":"Cichocki F, van der Stegen SJC, Miller JS. Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies. Blood. 2023;141:846\u201355. https:\/\/doi.org\/10.1182\/blood.2022016205.","journal-title":"Blood"},{"key":"4507_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jconrel.2023.09.037","volume":"363","author":"W Meng","year":"2023","unstructured":"Meng W, et al. Engineered mesenchymal stem cell-derived extracellular vesicles constitute a versatile platform for targeted drug delivery. J Control Release. 2023;363:235\u201352. https:\/\/doi.org\/10.1016\/j.jconrel.2023.09.037.","journal-title":"J Control Release"},{"key":"4507_CR35","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13287-023-03352-1","volume":"14","author":"ICS Calcat","year":"2023","unstructured":"Calcat ICS, et al. Harmonised culture procedures minimise but do not eliminate mesenchymal stromal cell donor and tissue variability in a decentralised multicentre manufacturing approach. Stem Cell Res Ther. 2023;14:120. https:\/\/doi.org\/10.1186\/s13287-023-03352-1.","journal-title":"Stem Cell Res Ther"},{"key":"4507_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13287-017-0555-9","volume":"8","author":"AK Batsali","year":"2017","unstructured":"Batsali AK, et al. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of wharton\u2019s jelly and bone marrow-derived mesenchymal stem cells. Stem Cell Res Ther. 2017;8:102. https:\/\/doi.org\/10.1186\/s13287-017-0555-9.","journal-title":"Stem Cell Res Ther"},{"key":"4507_CR37","doi-asserted-by":"publisher","first-page":"e2300381","DOI":"10.1002\/biot.202300381","volume":"19","author":"A Lopez-Fernandez","year":"2024","unstructured":"Lopez-Fernandez A, Garcia-Gragera V, Lecina M, Vives J. Identification of critical process parameters for expansion of clinical grade human wharton\u2019s jelly-derived mesenchymal stromal cells in stirred-tank bioreactors. Biotechnol J. 2024;19:e2300381. https:\/\/doi.org\/10.1002\/biot.202300381.","journal-title":"Biotechnol J"},{"key":"4507_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev-chembioeng-092319-075328","volume":"11","author":"AG Dixon","year":"2020","unstructured":"Dixon AG, Partopour B. Computational fluid dynamics for fixed bed reactor design. Annu Rev Chem Biomol Eng. 2020;11:109\u201330. https:\/\/doi.org\/10.1146\/annurev-chembioeng-092319-075328.","journal-title":"Annu Rev Chem Biomol Eng"},{"key":"4507_CR39","doi-asserted-by":"publisher","unstructured":"Klyachko NL, Arzt CJ, Li SM, Gololobova OA, Batrakova EV. Extracellular Vesicle-Based Therapeutics: Preclinical and Clinical Investigations. Pharmaceutics 12. https:\/\/doi.org\/10.3390\/pharmaceutics12121171 (2020).","DOI":"10.3390\/pharmaceutics12121171"},{"key":"4507_CR40","doi-asserted-by":"publisher","first-page":"1723260","DOI":"10.1080\/20013078.2020.1723260","volume":"9","author":"SB Fang","year":"2020","unstructured":"Fang SB, et al. Small extracellular vesicles derived from human mesenchymal stromal cells prevent group 2 innate lymphoid cell-dominant allergic airway inflammation through delivery of miR-146a-5p. J Extracell Vesicles. 2020;9:1723260. https:\/\/doi.org\/10.1080\/20013078.2020.1723260.","journal-title":"J Extracell Vesicles"},{"key":"4507_CR41","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/sctm.16-0226","volume":"6","author":"H Haga","year":"2017","unstructured":"Haga H, Yan IK, Takahashi K, Matsuda A, Patel T. Extracellular vesicles from bone Marrow-Derived mesenchymal stem cells improve survival from lethal hepatic failure in mice. Stem Cells Transl Med. 2017;6:1262\u201372. https:\/\/doi.org\/10.1002\/sctm.16-0226.","journal-title":"Stem Cells Transl Med"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04507-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04507-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04507-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T16:00:36Z","timestamp":1754409636000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04507-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4507"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04507-y","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures involving iPSCs were approved by the Ethics Committee of Beijing Luhe Hospital. The research project titled \u201cPeripheral blood collection from healthy people for iPSC cell bank construction and clinical use\u201d was approved on July 24, 2023 (2021-LHYW-043-04). Donors provided written informed consent for their participation in the study and the use of their tissue for research purposes. Human dermal fibroblasts were purchased from a commercial vendor, IMMOCELL. The company has confirmed that there was initial ethical approval for the collection of human materials and the derivation of cell lines and that the donors had signed informed consent. See for details:\n                      \n                      .All experimental procedures involving MSC cells approved by the Ethics Committee of Tsinghua Changgung Hospital. The research project titled \u201cClinical study on the safety, tolerability and preliminary efficacy of mesenchymal stem cell derived exosomes in the treatment of idiopathic pulmonary fibrosis\u201d was approved on July 31, 2023 (No.23346-4-02). Donors provided written informed consent for their participation in the study and the use of their tissue for research purposes.All animal procedures were performed in accordance with relevant laws and regulations governing the use and care of experimental animals and approved by the Institutional Animal Care and Use Committee (IACUC) of Allife Medicine (No. IAUCC-2024-160, Title: Safety and efficacy of mesenchymal stem cell-derived exosomes in the treatment of pulmonary fibrosis in mice; Date of approval: Feb 1, 2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors confirm their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was partially supported by Allife Medicne, Inc. Other authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"426"}}